Partial success of recombinant activated factor VIIa (rFVIIa) in severe hemorrhage in acquired von Willebrand disease

被引：0
|
作者：
Atallagh, F. [1 ]
Georges, B. [1 ]
Riu, B. [1 ]
Conil, J. M. [1 ]
Decun, J. F. [1 ]
Caranobe, C. [2 ]
Rischmann, P. [3 ]
Samii, K. [1 ]
Boneu, B. [2 ]
机构：
[1] Toulouse Univ Hosp, Anesthesiol & Intens Care Dept, Toulouse, France
[2] Toulouse Univ Hosp, Hematol Dept, Toulouse, France
[3] Toulouse Univ Hosp, Urol Dept, Toulouse, France
来源：
EUROPEAN JOURNAL OF ANAESTHESIOLOGY | 2004年 / 21卷
关键词：
D O I：
10.1097/00003643-200406002-00291
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
A-321
引用
下载
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [41] Recombinant von Willebrand factor -: Insight into structure and function through infusion studies in animals with severe von Willebrand disease
    Schwarz, HP
    Schlokat, U
    Mitterer, A
    Váradi, K
    Gritsch, H
    Muchitsch, EM
    Auer, W
    Pichler, L
    Dorner, F
    Turecek, PL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (02): : 215 - 225
  • [42] An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease
    Hancock, John M.
    Escobar, Miguel A.
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (03) : 157 - 161
  • [43] Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease
    Roussi, J
    Turecek, PL
    André, P
    Bonneau, M
    Pignaud, G
    Sollier, CBD
    Schlokat, U
    Dorner, F
    Schwarz, HP
    Drouet, L
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) : 361 - 372
  • [44] Safety, efficacy and pharmacokinetics of a recombinant von willebrand factor in patients with severe von willebrand disease: a prospective clinical trial
    Gill, J.
    Castaman, G.
    Windyga, J.
    Kouides, P.
    Ragni, M.
    Leebeek, F.
    Obermann-Slupetzky, O.
    Chapman, M.
    Fritsch, S.
    Pavlova, B. G.
    Presch, I
    Ewenstein, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 127 - 127
  • [45] Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants
    Olomu N.
    Kulkarni R.
    Manco-Johnson M.
    Journal of Perinatology, 2002, 22 (8) : 672 - 674
  • [46] Severe obstetric bleeding treated with recombinant activated factor VII (rFVIIa)
    Segal, S
    Shemesh, IY
    Blumental, R
    Yoffe, B
    Laufer, N
    Ezra, Y
    Levy, I
    Mazor, M
    Martinowitz, U
    2ND WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY, 2001, : 43 - 46
  • [47] Recombinant activated factor VII (rFVIIa) in the treatment of four cases of severe hemorrhage from portal hypertension (PH)
    Romero, R
    Pellicer, F
    Jimenez, M
    Gomez, M
    Sendon, A
    Guerrero, MD
    Herrerias, JM
    GASTROENTEROLOGY, 2002, 122 (04) : A79 - A79
  • [48] Combination therapy with activated prothrombin complex concentrate (APCC) and recombinant factor VIIa (rFVIIa) in patients with severe hemophilia and inhibitors.
    Schneiderman, J
    Nugent, DJ
    Young, G
    BLOOD, 2002, 100 (11) : 696A - 696A
  • [49] RECOMBINANT FACTOR VIIA(RFVIIA) INDUCED SHORTENING OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) OF FACTOR-VIII DEFICIENT PATIENTS - AN INVITRO ARTIFACT
    MACIK, BG
    MONROE, DM
    NEMERSON, Y
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1311 - 1311
  • [50] Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage
    Hamaekers, Ankie E. W.
    van Mook, Walther N. K. A.
    Offermans, J. P. M.
    Marcus, Marco A. E.
    AMERICAN JOURNAL OF CRITICAL CARE, 2006, 15 (04) : 399 - 401
12345